The public is outraged about reports that Citi, Goldman Sachs Group Inc. and Morgan Stanley along with other big New York employers, received hundreds, even thousands, of H1N1 vaccine doses before hospitals and other healthcare providers, many of which have run out of the precious drug. For Goldman Sachs, accused of unfairly benefiting from government bailout funds and its close relationships with administration officials, the problem is especially acute. Jokes are already circulating on Wall Street about how Goldman will create derivatives out of the few doses it has and begin trading them.